H.R.5334

Congress: 112th

Sponsor: Representative Bilbray, Brian P. (05/07/2012)

Committees: House - Energy and Commerce

Description: To amend chapter V of the Federal Food, Drug, and Cosmetic Act to expedite the development and review of breakthrough therapies.

Vote Result:

Lastest Action: 05/11/2012 Referred to the Subcommittee on Health. (All Actions)